The Paxil Papers [Source - Christopher Lane]
This Paxil Fact File, containing confidential information, was drafted and distributed by SmithKline Beecham in 1998--for internal use only.
Foreword by Paul N. Jenner, Director and Vice President of Neuroscience and Strategic Product Development
Section 1: Towards the Second Billion -- All SSRIs Are Not the Same
Section 2: New Indications: Social Anxiety Disorder / Social Phobia
Section 3: Issues Management: Managing the Discontinuation Issue.
"Duration of Treatment and Depression: Relapse and Recurrence Rates" (February 2001; GlaxoSmithKline Confidential--Internal Use Only).
"Paxil CR" Product Monograph (GlaxoSmithKline; November 1, 2005).
Paxil Litigation Documents (Filed Under Seal; November 11, 2007).
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING